Molecular biology of lung cancer: clinical implications
JE Larsen, JD Minna - Clinics in chest medicine, 2011 - chestmed.theclinics.com
Lung cancer is the leading cause of cancer-related death in men and women in the United
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
Molecular biology of lung cancer: clinical implications.
JE Larsen, JD Minna - Clinics in Chest Medicine, 2011 - europepmc.org
Lung cancer is the leading cause of cancer-related death in men and women in the United
States accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
States accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
[引用][C] Molecular Biology of Lung Cancer: Clinical Implications
JE Larsen, JD Minna - Clinics in Chest Medicine, 2011 - cir.nii.ac.jp
[HTML][HTML] Molecular Biology of Lung Cancer: Clinical Implications
JE Larsen, JD Minna - Clinics in Chest Medicine, 2011 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-related death in men and women in the United
States accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
States accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
Molecular Biology of Lung Cancer: Clinical Implications
JE Larsen, JD Minna - Clinics in Chest Medicine, 2011 - utsouthwestern.elsevierpure.com
Lung cancer is a heterogeneous disease clinically, biologically, histologically, and
molecularly. Understanding the molecular causes of this heterogeneity, which might reflect …
molecularly. Understanding the molecular causes of this heterogeneity, which might reflect …
Molecular Biology of Lung Cancer: Clinical Implications
JE Larsen, JD Minna - Lung Cancer, An Issue of Clinics in Chest …, 2011 - books.google.com
Lung cancer is the leading cause of cancer-related death in men and women in the United
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
Molecular biology of lung cancer: clinical implications
JE Larsen, JD Minna - Clinics in chest medicine, 2011 - pubmed.ncbi.nlm.nih.gov
Lung cancer is a heterogeneous disease clinically, biologically, histologically, and
molecularly. Understanding the molecular causes of this heterogeneity, which might reflect …
molecularly. Understanding the molecular causes of this heterogeneity, which might reflect …
Molecular biology of lung cancer: clinical implications.
JE Larsen, JD Minna - Clinics in Chest Medicine, 2011 - europepmc.org
Lung cancer is a heterogeneous disease clinically, biologically, histologically, and
molecularly. Understanding the molecular causes of this heterogeneity, which might reflect …
molecularly. Understanding the molecular causes of this heterogeneity, which might reflect …